6,16.BETA.-DIMETHYL-20-OXO-11.BETA.,17.ALPHA.,21-TRIOL-2'-(P-FLUOROPHENYL)PREGNA-4,6-DIENO(3,2-C)PYRAZOLE
UNII 90Q52N2EEN
Substance Identification & Data
This profile provides standardized clinical and technical data for 6,16.beta.-dimethyl-20-oxo-11.beta.,17.alpha.,21-triol-2'-(p-fluorophenyl)pregna-4,6-dieno(3,2-c)pyrazole, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 90Q52N2EEN.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 31738-10-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C30H35FN2O4 HMIRYTLYTWFOPG-CPWYQTSJSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 6,16.beta.-dimethyl-20-oxo-11.beta.,17.alpha.,21-triol-2'-(p-fluorophenyl)pregna-4,6-dieno(3,2-c)pyrazole. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.